Boost Sales of Diabetes and Weight Loss Drugs in India
Novo Nordisk has reported a significant increase of <strong>40%</strong> in sales of diabetes and weight loss medications in India last month due to substantial price reductions. This surge occurs despite the entry of generic GLP-1 drugs into the market.